Design: Cross-sectional study.
INTRODUCTION
The incidence of epidermoid anal cancer is reported to have increased in recent decades and may be even higher among HIV-positive men who have sex with men (MSM) [1] [2] [3] [4] . There is strong evidence that anal squamous intraepithelial lesions (SIL) -the putative precursor lesion -and anal cancer are both linked to some Human Papillomavirus (HPV) infections [4, 5] . Detection of anal HPV through molecular techniques is frequent in both HIV-infected MSM and women [4, 6] , and to a lesser extent in HIV-negative individuals. In two recent reports, anal HPV was also detected in HIV-infected heterosexual males in the absence of anal intercourse [7, 8] . Similarly, detection of anal SIL through anal cytology samples is more frequent in HIV-positive MSM than in HIV-negative ones [9] , and risk for progression from low-grade SIL toward high-grade SIL is higher in HIV-infected MSM than in HIV-negative MSM [10] .
Since the second half of the 90's, highly active antiviral therapy (HAART) has dramatically decreased HIV morbidity and mortality. The effect of HAART on the incidence of anal cancer, precursor lesions and HPV prevalence can be complex and results reported in the literature are conflicting [11] [12] [13] . On the one hand, the induced immune recovery could reduce the prevalence of HPV infection, anal SIL and their evolution toward dysplasia; on the other hand, the increase in the sexual activity and lengthened survival associated with HAART may paradoxically lead to an opposite effect [9, 10, 14] .
Anal intraepithelial HPV infection may lead to different types of macroscopic lesions, depending on HPV types, with non-oncogenic HPV types leading to benign lesions usually named condyloma and oncongenic HPV types, such as types 16 and 18, leading to intraepithelial dysplasia. As HPV-induced anal dysplasia has been associated with an increased risk of anal cancer, it seemed important to us in the HAART era to determine the prevalence of these different types of macroscopic HPV-related anal lesions [1, 15] .
We report here the results of a systematic screening for macroscopic anal HPV related lesions with a systematic search for intraepithelial dysplasia or cancer in a large population of HIV-infected individuals. Our objective was to determine the prevalence of these lesions (condyloma and intraepithelial dysplasia) in the HAART era in consecutive MSM, women and heterosexual men and to identify their risks factors.
METHODS

Patients and Study Design
Beginning in May 2003 and during a 12-month period, screening for anal macroscopic HPV related lesion was systematically proposed by the primary care physician during a routine follow-up visit to a sample of HIV-infected outpatients in the infectious diseases units of Bichat Claude Bernard University hospital in Paris, France. The sample was composed of all consecutive patients consulting any of the medical doctors present during 3 randomlydetermined half-days per week. The 3 selected half-days were modified 3 times during the study period to allow for the screening of a representative sample of patients.
Data Collected
We collected the following data for each patient (whether they accepted screening or not): sex, age, geographic origin, risk factors for HIV infection, mean interval since the detection of HIV positive serostatus, worst Centers for Disease Control and Prevention stage of disease, CD4 cell nadir, CD4 cell count and HIV-RNA level at the time of the consultation as well as current antiretroviral therapy. In patients who refused the screening, the reason for the refusal was noted (lack of time, anal HPV-related lesion already monitored by a proctologist, unwillingness). In patients who accepted the screening, a standardized questionnaire was filled out after anal examination by the proctologist. This questionnaire asked for information regarding previous sexual transmitted diseases, history of genital and anal condyloma including the date and the type of the last treatment, and sexual activities and practices (anal sexual intercourse, frequency of acts of sexual intercourse per month, number of sexual partners per year, condom use). Men were considered to be homosexual or bisexual men if the reported HIV transmission risk factor was homosexuality or if they declared having receptive anal intercourse (hereafter referred to as homosexual men).
Anal Examination
Anal examination was performed immediately following the HIV consultation in the infectious diseases unit by the same experienced proctologist (internal medicine physician with gastroenterology subspecialty training in proctology). The examination consisted in an ocular inspection (with and without aceto-white test which is considered to increase the visibility of HPV intra-epithelial lesions) of the anal margin (anal area visible before anoscopy examination) and an anal canal examination through anoscopy. Acetic acid was applied to the total area of anal margin and canal. HPV intra-epithelial lesion was suspected in case of either an acetowhite area or a slightly elevated mucosa resembling tumors white to pink in color or of exophytic elevated lesions easily distinguishable from normal mucosa.
Biopsy was systematically performed to confirm the diagnosis of HPV related lesion. In the case of lesions found during the screening, patients were asked if they had any related discomfort. In males, external genital organs were also examined.
Histological Analysis
HPV intra-epithelial lesions were diagnosed by two independent observers using 4-m-thick, paraffin-embedded sections of formalin-fixed tissue and stained with HES. 
In situ molecular techniques for detection of HPV
In situ hybridization (ISH) was used for HPV screening and typing. For ISH, biotinylated and fluorescein isothiocyanate-labeled commercial genomic DNA probes were purchased from Argène (Varhiles, France) and Dakopatt (Glostrup, Denmark). ISH was performed according to our previously published protocol using probes specific to the various types of HPV: 6, 11, 16, 18, 31 and 33 (1). When previous specific ISH were negative, ISH was performed using low (HPV 6/11) and high risk ( 
Statistical Analysis
Patients were classified into three levels: patients with no HPV related lesions, patients with anal condyloma and patients with histological anal dysplasia. Thus, we used a polytomous logistic regression model to assess the association between categories of patients and characteristics of patients. Characteristics that were related to categories of patients in bivariate analysis were kept in the multivariate analysis with stepwise selection of the covariables. In bivariate analysis, qualitative variables were compared using chi-squared or Fisher's exact test, when appropriate, and quantitative variables were compared by analysis of variance. In multivariate analysis, the "patients with no lesions" category was the reference group. A significance level of 0.10 was required to include a variable in the model and a significance level of 0.05 was required for a variable to remain in the model. Odds ratios with a 95% confidence interval (CI) were estimated. All statistical analyses were performed with SAS software, version 9.1 (SAS institute).
Ethics
All patients received written information before examination, and the local ethics committee approved the study.
RESULTS
Anal examination was proposed to 516 HIV-infected patients, 473 (92%) of whom accepted. Among the 43 patients who refused anal examination, 35 were male (11 homosexual and 24 heterosexual) and 8 female. The reasons for refusal included the following: known anal HPV intra-epithelial lesion already monitored by a proctologist (7 patients); lack of time (13 patients of the 61 patients with dysplasia; 3 patients also had high-risk oncogenicity HPV without dysplasia. One invasive anal carcinoma was detected in one patient.
Seventy patients (15%) had a previous history of anal condyloma, the last treatment of which had been performed on average 8 years ago. Seventy-seven percent of patients with anal HPV related lesion had no discomfort. Among the 473 screened patients, screening for anal HPV intra-epithelial lesion had been previously proposed to only 10 (2.1 %), of those 9
were homosexual and 1 was a woman. No patients had previously undergone anal cytology sampling. Table 2 shows patients characteristics associated with anal condyloma or anal histological dysplasia among homo-or bisexual men, heterosexual men and women. Table 3 shows bivariate analysis of associated factors for anal condyloma and for anal histological dysplasia. Multivariate analysis for independent risk factors associated with anal condyloma and anal histological dysplasia, compared to patients with no anal lesions is displayed in 
DISCUSSION
The systematic screening for anal macroscopic HPV related lesions conducted in this study on this large HIV-infected population during the HAART era revealed a high prevalence of anal condyloma (10%) and histological dysplasia (13%), of which half were exclusively endoanal. These findings concern not only the homosexual male population but also the heterosexual male population and the female population.
The comparison of the characteristics of this screened population with those of the population who refused the screening in this study shows that they were comparable except for the proportion of IV-drug addiction, which was a more frequent HIV transmission risk factor in the population of patients who refused the screening. The reason of the refusal in this population was essentially due to unwillingness. As the selected sample was randomly chosen, we assume that the studied population is representative of the whole population of HIV-infected outpatients seen in our hospital. One limitation of our study could be the referral bias of a large tertiary-care center. Because the study was conducted at a single center, we The relation between anal condyloma considered as a benign lesion and anal histological dysplasia is very close as both diseases are linked to HPV infection and probably share transmission risk behaviours. A recent cohort study showed an incidence of anal intraepithelial neoplasia and anal cancer of 0.1/1000 patient/year in the HIV-infected population with anal condyloma [15] . Similarly, Frisch et al, in analysing risk factors for anal cancer in women, reported an odds ratio of 9.8 in women with a history of anal condyloma [3] . Looking specifically at associated factors of each disease may help understand the relation between these two types of anal HPV infection.
There is no similar study in the literature performed before or during the HAART era to which our study could be compared as regards to the prevalence of histologically proved anal HPV infection. Our results could however be analysed in light of the prevalence of anal HPV shedding in the homosexual HIV infected men, which has been extensively studied. The presence of condyloma and anal histological dysplasia detected in the heterosexual male population without any history of anal intercourse, which has never previously been studied,
is not surprising as, on the one hand, anal HPV shedding has been detected in heterosexual men in Piketty et al. study [7, 8] , and on the other hand, husbands of women with cervical cancer have been found at an increased risk for anal cancer [17] . However, in the study of Piketty et al., the heterosexual male population with no history of anal intercourse was restricted to male injection drug users and therefore did not include all categories of heterosexuals [7] . Interestingly, the increase in the rate of HPV related lesions in HIVinfected homosexual patients as compared to heterosexual patients found in the present study (36.5 % vs 14.6%) is consistent with the 2-fold higher rate of HPV detection reported in homosexual men as compared to heterosexual in a previous study (85% versus 46%) [7] .
The prevalence of anal HPV related lesions (11.3%) in our population of women is much higher than that reported in a previous study (1,6%) [18] . The difference could be due to different reasons. First, it could be related to the examined anal region. In fact, Conley et al.
looked only for anal margin localisation without looking for anal canal localisation. However, our prevalence remained higher when we did not take into account the 3 % (5/150 women) of intra anal condyloma. Another reason may be the experience of the screening doctor. In our study, the examinations were performed by a senior proctologist, whereas they were performed by gynaecologists in the study of Conley et al. The prevalence we found in our study could not be overestimated because condyloma diagnosis in each case was based on histological result.
Multivariate analysis of risk factors associated with on the one hand condyloma and on the other hand anal histological dysplasia reveals both common but also distinct characteristics. In fact, neither virological (HIV-RNA) characteristics, CDC stage, geographic origins, length of known HIV positive serology, nor use of HAART were associated with the presence of anal condyloma or anal histological dysplasia. On the contrary, CD4 cell count below 200 x 10 6 cells/L at the time of the screening was independently associated with the presence of condyloma whereas it was not for histological dysplasia. In the literature, there are conflicting data concerning the identification of CD4 cell count, CD4 nadir or current use of HAART as risk factors for HPV shedding or cytological dysplasia in homosexual men, heterosexual male injection drug users [7, 8, 19] and in women [4, 13, 18, 20] . Given our results, and given that other authors have studied only anal HPV shedding rather than HPV related histological lesions, we can hypothesise that immunity does not play the same role in controlling anal HPV shedding, benign anal HPV lesions (condyloma, related to nononcogenic HPV) development or anal dysplasia (related to oncogenic HPV) development.
History of anal condyloma was a strong predictor of the detection of both HPV related lesions (anal condyloma and histological dysplasia). Of note is that the time interval between
the last treatment of previous anal condyloma lesion and the screening was rather long (average 8 years) and that the treatment dates back to the pre-HAART period in most patients.
As the large majority of our patients were receiving HAART and were in virological success, we hypothesise that their immunological status improved between these two periods, but this improvement was not sufficient to prevent the recurrence of HPV-related lesions. Results are similar to those of recent studies in which no effect of HAART on HPV related lesions was observed [13, 21] .
Sexual practices were also independently associated with anal HPV lesions, such as the number of incidents of sexual intercourse which has been previously reported to be associated with abnormal anal cytologic findings in homosexual men [7] . However, in our population, the independent association between anal HPV lesion and the number of incidents of sexual intercourse was significant for condyloma whereas it was only a trend for histological dysplasia. Receptive anal intercourse was a risk factor both for condyloma and histological dysplasia, which underlines the need to identify these sexual practices in women and bisexual men. However, as noted by others, the absence of anal intercourse cannot be used to rule out with certainty the presence of anal lesions or to systematically exclude such patients from a detection process [4, 7, 8] .
Histologically proved anal HPV lesions and/or high-risk HPV anal infection are thus frequent in this large population of HIV-infected patients including patients previously not considered to be at risk for anal cancer. Given their frequency and their potential relation to anal neoplasia, systematic screening should be considered. Whether this detection should concern the entire HIV-infected population or only those patients at highest risk of HPVrelated lesion has yet to be determined. The screening guidelines could differ between homosexual men, heterosexual men and women. These guidelines should also be implemented according to a criterion of cost-effectiveness. A pragmatic approach could be proposed: in homosexual men, the presence of HPV related lesion with histological sign of dysplasia in more than one fifth of patients suggests that this detection should include all homosexual HIV-infected men regardless of CD4 cell count or use of antiretrovirals, and especially in the case of frequent sexual activity and of history (even long past) of anal HPV lesions. In heterosexual men and in women, detection should probably focus on patients with a history of HPV-related diseases and previous mentioned at-risk behaviors. This screening should also be accompanied by prevention information to help reduce the rate of the at-risk behaviors for HPV exposure.
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